CFO
MEDP icon

CVA Family Office’s Medpace MEDP Stock Holding History

CVA Family Office’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$20.1K Buy
38
+3
+9% +$1.39K ﹤0.01% 810
2026
Q1 		$16.8K Buy
35
+32
+1,067% +$16.4K ﹤0.01% 847
2025
Q4 		$1.69K Hold
3
– – ﹤0.01% 1026
2025
Q3 		$1.54K Buy
3
+1
+50% +$437 ﹤0.01% 1044
2025
Q2 		$628 Sell
2
-3
-60% -$901 ﹤0.01% 1177
2025
Q1 		$1.52K Buy
5
+4
+400% +$1.35K ﹤0.01% 1039
2024
Q4 		$332 Buy
+1
New +$339 ﹤0.01% 1267
2024
Q3 		– Sell
-3
Closed -$1.24K – 1321
2024
Q2 		$1.24K Buy
+3
New +$1.19K ﹤0.01% 1036

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

CVA Family Office's MEDP Position: Q2 2026 in Review

CVA Family Office increased its Medpace (MEDP) stake by 8.6% in Q2 2026, buying an estimated $1.39K and bringing the position to 38 shares worth $20.1K. The position accounts for ﹤0.01% of the portfolio, ranked #810.

CVA Family Office first reported a position in MEDP in Q2 2024 and has held it in 8 quarters since. 700 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • CVA Family Office held 38 shares of Medpace worth $20.1K as of Q2 2026.
  • CVA Family Office bought 3 Medpace shares in Q2 2026, an estimated $1.39K.
  • Medpace made up ﹤0.01% of CVA Family Office's portfolio in Q2 2026, its #810 holding.
  • CVA Family Office first reported a position in Medpace in Q2 2024 and has held it in 8 quarters since.
  • 700 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on CVA Family Office's 13F filing for Q2 2026, filed 7 Aug 2026.